GmbH, Germany). The location of each captured immunostained spread was recorded so that it could be relocated on the slide after FISH. Electron microscopy was carried out using a JEM-1400 electron microscope (JEOL, Tokyo, Japan) at 80 kV. All microscopy studies were carried out at the Center for Microscopic Analysis of Biological Objects of SD RAS (Novosibirsk, Russia). Corel PaintShop Pro X6 (Corel) was used for a correction of image brightness and contrast. Chromosome measurements and generation of recombination maps of GRCs. Centromeres were identified by ACA foci. MLH1 signals were only scored if they were localized on SCs. The length of the SC was measured in micrometers and the positions of MLH1 foci in relation to the centromere were recorded using MicroMeasure 3.3 30. SCs of GRC and macrochromosomes were identified by their relative lengths and centromeric indexes. SC1 is the largest submetacentric. SC2 and SC3 are large subacrocentrics of similar sizes but different centromeric indexes. SC4 is middle size metacentric, SC5 and SC6 are subacrocentrics of the same size, which differ from each other in the centromeric indexes. On bone marrow metaphase chromosome spreads, Z and W are identified as a pair of non-matching macrochromosomes: metacentric and submetacentric (correspondingly). At SC spreads, ZW is identified as macrobivalent with misaligned centromeres and/or asynapsed ends of the axial elements. GRC is identified as the only acrocentric macrobivalent or univalent. To generate recombination maps, we divided the length of the SC into equal intervals approximately equal to 1 µm and plotted the proportion of MLH1 foci located in each interval. STATISTICA 6.0 software package (StatSoft, Tulsa, OK, USA) was used for descriptive statistics. All results were expressed as mean ± SD; p < 0.05 was considered as statistically significant.

A new esterase gene from thermophilic bacteria Ureibacillus thermosphaericus was cloned into the pET32b vector and expressed in Escherichia coli BL21(DE3). Alignment of the estUT1 amino acid sequence revealed the presence of a novel canonical pentapeptide (GVSLG) and 41-47% identity to the closest family of the bacterial lipases XIII. Thus the esterase estUT1 from U. thermosphaericus was assigned as a member of the novel family XVIII. It also showed a strong activity toward short-chain esters (C2-C8), with the highest activity for C2. When p-nitrophenyl butyrate is used as a substrate, the temperature and pH optimum of the enzyme were 70-80 °C and 8.0, respectively. EstUT1 showed high thermostability and 68.9 ± 2.5% residual activity after incubation at 70 °C for 6 h. Homology modeling of the enzyme structure showed the presence of a putative catalytic triad Ser93, Asp192, and His222. The activity of estUT1 was inhibited by PMSF, suggesting that the serine residue is involved in the catalytic activity of the enzyme. The purified enzyme exhibited high stability in organic solvents. EstUT1 retained 85.8 ± 2.4% residual activity in 30% methanol at 50 °C for 6 h. Stability at high temperature and tolerance to organic solvents make estUT1 a promising enzyme for biotechnology application.

Background/Aim: Oncolytic adenoviruses are promising therapeutic agents against both the bulk of tumor cells and cancer stem cells. The present study intended to test the oncolytic capability of adenovirus serotype 6 (Ad6), which has a lower seroprevalence and hepatotoxicity relatively to adenovirus 5 (Ad5), against the glioblastoma and its cancer stem cells. Materials and Methods: Oncolytic efficacy of Ad6 was compared to widespread Ad5 both in vitro and in vivo, using the U87 and U251 human glioblastoma cell lines and subcutaneously transplanted U87 cells in SCID mice, respectively. Results: Ad6 had a dose-dependent cytotoxicity toward glioblastoma cells in vitro and its intratumoral injections lead to a significant (p<0.05) decrease in volume of U87 xenografts, similarly to Ad5. Based on the innate capability of glioblastoma cancer stem cells to internalize a fluorescent-labeled double-stranded DNA probe, the spatial localization of these cells was estimated and it was shown that the number of cancer stem cells tended to decrease under adenovirus therapy as compared to the control group. Conclusion: Ad6 was shown to be a promising agent for treating glioblastomas.

Background: We have characterized the human cell line arised from the Epstein-Barr virus (EBV) positive multiple myeloma aspirate subjected to the long-term cultivation. This cell line has acquired the ability to form free-floating spheres and to produce a xenograft upon transplantation into NOD/SCID mice.Methods: Cells from both in vitro culture and developed xenografts were investigated with a number of analytical approaches, including pathomorphological analysis, FISH analysis, and analysis of the surface antigens and of the VDJ locus rearrangement. Results:The obtained results, as well as the confirmed presence of EBV, testify that both biological systems are derived from B-cells, which, in turn, is a progeny of the EBV-transformed B-cellular clone that supplanted the primordial multiple myeloma cells. Next we assessed whether cells that (i) were constantly present in vitro in the investigated cell line, (ii) were among the sphere-forming cells, and (iii) were capable of internalizing a fluorescent TAMRA-labeled DNA probe (TAMRA+ cells) belonged to one of the three types of undifferentiated bone marrow cells of a multiple myeloma patient: CD34+ hematopoietic stem cells, CD90+ mesenchymal stem cells, and clonotypic multiple myeloma cell.Conclusion: TAMRA+ cells were shown to constitute the fourth independent subpopulation of undifferentiated bone marrow cells of the multiple myeloma patient. We have demonstrated the formation of ectopic contacts between TAMRA+ cells and cells of other types in culture, in particular with CD90+ mesenchymal stem cells, followed by the transfer of some TAMRA+ cell material into the contacted cell.

No abstract